Showing results (561-570 of 692) with videos related to
Sort By:
Pageof 70
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1993
The Functional Assessment of Cancer Therapy scale: development and validation of the general measureD F Cella, D S Tulsky, G Gray, et al.South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|April 8, 2020
HIV research in South Africa: Advancing lifeG Gray, Tanya Doherty, Lerato Mohapi, et al.Expert Opinion on Drug Safety|August 8, 2024
Vaccine pharmacovigilance in South Africa: successes and limitations of current approachesJ Peter, A Takalani, J C Meyer, et al.The American Journal of Pathology|July 8, 1999
Mitochondrial DNA depletion syndrome is expressed in amniotic fluid cell culturesJ C Blake, J W Taanman, A M Morris, et al.International Journal of Cancer|April 20, 2007
DOK4/IRS-5 expression is altered in clear cell renal cell carcinomaNael Al-Sarraf, Johanne Nørvig Reiff, Jane Hinrichsen, et al.Journal of Virology|April 1, 1992
Mutations in the principal neutralization determinant of human immunodeficiency virus type 1 affect syncytium formation, virus infectivity, growth kinetics, and neutralizationR J Grimaila, B A Fuller, P D Rennert, et al.JACC. Cardiovascular Interventions|September 19, 2024
Long-Term Results of the Atrial Septal Defect Occluder ASSURED Trial for Combined Pivotal/Continued Access CohortsAthar M Qureshi, Robert J Sommer, Gareth Morgan, et al.JAMA Network Open|March 9, 2022
Comparison of 3 Randomized Clinical Trials of Frontline Therapies for Malignant Pleural MesotheliomaTomer Meirson, Francesca Pentimalli, Francesco Cerza, et al.Journal of Virology|April 24, 2020
Discrete Virus Factories Form in the Cytoplasm of Cells Coinfected with Two Replication-Competent Tagged Reporter Birnaviruses That Subsequently Coalesce over TimeElle A Campbell, Vishwanatha R A P Reddy, Alice G Gray, et al.British Journal of Haematology|October 16, 1999
A simple, robust, validated and highly predictive index for the determination of risk-directed therapy in acute myeloid leukaemia derived from the MRC AML 10 trial. United Kingdom Medical Research Council's Adult and Childhood Leukaemia Working PartiesK Wheatley, A K Burnett, A H Goldstone, et al.Pageof 70